Novartis AG
- NVS
- NYSE
- Consumer Products
- Latest 73.29
- Currency US$
- Change 0.65
- Percent Change 0.895 %
- Volume 1,422,445
- Mon Jun 17, 2013 4:02 PM EDT NYSE data delayed 15 minutes.
The Globe and Mail
- Open 73.46
- Previous Close 72.64
- High 73.68
- Low 72.95
- Bidx0 71.29
- Askx0 74.35
- 52-week High -- 75.728
- 52-week Low -- 53.35
- Beta 0.473
- Market Cap 177,407.24M
- EPS 3.91
- P/E 18.74
- Forward P/E 13.111
- PEG 3.24
- Annual Dividend 2.53
- Yield 3.452
News
- Big Pharma consolidation not thrilling investors
- MARKET PULSE-Sina Corp, Conceptus, J C Penney, Actavis, Moody's
- MARKET PULSE-Moody's, Northern Tier, Actavis, Loews, Eaton, Conceptus
- Glaxo loses thirst for iconic beverage brands
- Globe's biggest drug makers said weighing bids for Brazil’s ‘crown jewel’
- Novartis highlights new findings in advancing care for patients with 170 abstracts in breast, lung and blood cancers at ASCO and EHA
- Novartis Pharmaceuticals Corporation disputes allegations in two US Government lawsuits and looks forward to a fair discussion of the facts
- Recently Launched Products Support Novartis Sales in Third Quarter, Offsetting Patent Expiry; Pharmaceuticals Well-Positioned with Further Pipeline Progress
- Leeza Gibbons joins Novartis to improve caregiving experience for millions of Americans through real-world peer advice on AlzheimersDisease.com
- Higher dose of Novartis drug Exelon® Patch approved by FDA for patients with mild to moderate Alzheimer's disease
Financials & Calendars
- Sales $56,954,000,000
- Earnings $9,625,000,000
- Return on Equity 14.12%
- Cash Flow --
- Cash $4,706,000,000
- Current Ratio 1.02
12 months ended Mar 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
- Assets $121,011,000,000
- Liabilities $53,863,000,000
- Liabilities-to-Equity Ratio 0.80
Price Ratios
- Price to Sales 3.11
- Price to Book 2.64
- Price to Cash Flow n/a
Event Calendar
| Event | Last | Next | ||
|---|---|---|---|---|
| Earnings | Apr 24 | $1.25 | Jul 18 | $1.32 |
| Surprises | Apr 24 | 4.00% | n/a | n/a |
| Dividends | Feb 26 | $2.53 | n/a | n/a |
| Splits | n/a | -- | n/a | n/a |
12 months ended Jun 18, 2013.
A look at major corporate events and financial announcements that are coming up.
Company Information
About the Company
Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work.
Officers
- Daniel Vasella Chairman
- Joseph Jimenez Chief Executive Officer
- Company Type: n/a
- Company Status: n/a
- Full-time Employees: n/a
-
Incorporation:
United States,
n/a -
Top 1000 Ranking:
Profit: n/a
Revenue: n/a
Assets: n/a
Ideas & Discussion
Live Discussion of NVS on StockTwits